Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Current Leases (2019 - 2025)

Historic Current Leases for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to $5.3 million.

  • BridgeBio Pharma's Current Leases rose 1508.7% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 1508.7%. This contributed to the annual value of $4.5 million for FY2024, which is 915.7% up from last year.
  • According to the latest figures from Q3 2025, BridgeBio Pharma's Current Leases is $5.3 million, which was up 1508.7% from $4.8 million recorded in Q2 2025.
  • Over the past 5 years, BridgeBio Pharma's Current Leases peaked at $5.3 million during Q3 2025, and registered a low of $3.7 million during Q1 2023.
  • Moreover, its 5-year median value for Current Leases was $4.5 million (2024), whereas its average is $4.4 million.
  • As far as peak fluctuations go, BridgeBio Pharma's Current Leases surged by 5167.33% in 2021, and later plummeted by 2557.72% in 2022.
  • BridgeBio Pharma's Current Leases (Quarter) stood at $4.9 million in 2021, then fell by 25.58% to $3.7 million in 2022, then grew by 12.33% to $4.1 million in 2023, then rose by 9.16% to $4.5 million in 2024, then rose by 17.49% to $5.3 million in 2025.
  • Its Current Leases stands at $5.3 million for Q3 2025, versus $4.8 million for Q2 2025 and $5.2 million for Q1 2025.